Enteral Glutamine in Neurologically-injured Patients
Randomized, Placebo-controlled Clinical Trial of Enteral Glutamine Supplementation in Neurologically-injured Patients
1 other identifier
interventional
102
1 country
1
Brief Summary
Nutrition is an important part of the recovery process after having a head injury so that subjects can gain strength and fight off infection. Liquid nutrition formulas are often given to patients through a tube that has been placed into the intestines for feeding when they are unable to eat on their own. Some reports suggest that nutrition with extra amounts of the amino acid called glutamine may decrease infections and hospital stay in severely injured patients.The purpose of this study is to evaluate if giving extra amounts of an amino acid called glutamine with liquid nutrition formulas will decrease the risk of infection and length of stay in the intensive care unit after having a head injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jan 2003
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 20, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2008
CompletedOctober 1, 2015
September 1, 2015
5 years
September 13, 2005
September 29, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Nosocomial infections
throughout study
Secondary Outcomes (2)
Multiple organ dysfunction syndrome
throughout the study
Nutritional outcome parameters
throughout the study
Study Arms (2)
1
EXPERIMENTALNutritional supplement
2
PLACEBO COMPARATORplacebo
Interventions
Eligibility Criteria
You may qualify if:
- Males
- Nonpregnant females
- Aged 18-75 years old
- Glasgow Coma Scores of 3-12
- Injury Severity Scores greater than or equal to 20
- Requiring enteral nutrition for a minimum of 5 days
You may not qualify if:
- Documented hepatic dysfunction
- Acute renal failure (creatinine clearance \< 15 mL/min)
- Gastrointestinal malabsorptive disorder
- Infection at time of admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Wisconsin
Madison, Wisconsin, 53792, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gordon S Sacks, PharmD
University of Wisconsin, Madison
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 20, 2005
Study Start
January 1, 2003
Primary Completion
January 1, 2008
Study Completion
January 1, 2008
Last Updated
October 1, 2015
Record last verified: 2015-09